Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Cappabianca

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Biology|September 2, 2004
Nature of the accessible chromatin at a glucocorticoid-responsive enhancerMichelle Flavin, Lucia Cappabianca, Clémence Kress, et al.
Oncotarget|March 2, 2018
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptationAntonietta Rosella Farina, Lucia Cappabianca, Luciana Gneo, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2004
TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importanceAntonella Tacconelli, Antonietta R Farina, Lucia Cappabianca, et al.
European Journal of Biochemistry|September 17, 2002
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogenAntonietta R Farina, Antonella Tacconelli, Lucia Cappabianca, et al.
Future Oncology (London, England)|March 25, 2006
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastomaAntonella Tacconelli, Antonietta R Farina, Lucia Cappabianca, et al.
Experimental Cell Research|May 17, 2003
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT siteLucia Cappabianca, Antonietta Rosella Farina, Antonella Tacconelli, et al.
Oncotarget|September 29, 2015
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activityAntonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 16, 2020
Hypoxia-induced alternative splicing: the 11th Hallmark of CancerAntonietta Rosella Farina, Lucia Cappabianca, Michela Sebastiano, et al.
Experimental Cell Research|December 4, 2003
Thioredoxin inhibits microvascular endothelial capillary tubule formationAntonietta R Farina, Antonella Tacconelli, Lucia Cappabianca, et al.
Oncotarget|November 9, 2016
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastomaLuciana Gneo, Pierdomenico Ruggeri, Lucia Cappabianca, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biology|September 2, 2004
Nature of the accessible chromatin at a glucocorticoid-responsive enhancerMichelle Flavin, Lucia Cappabianca, Clémence Kress, et al.
Oncotarget|March 2, 2018
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptationAntonietta Rosella Farina, Lucia Cappabianca, Luciana Gneo, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2004
TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importanceAntonella Tacconelli, Antonietta R Farina, Lucia Cappabianca, et al.
European Journal of Biochemistry|September 17, 2002
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogenAntonietta R Farina, Antonella Tacconelli, Lucia Cappabianca, et al.
Future Oncology (London, England)|March 25, 2006
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastomaAntonella Tacconelli, Antonietta R Farina, Lucia Cappabianca, et al.
Experimental Cell Research|May 17, 2003
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT siteLucia Cappabianca, Antonietta Rosella Farina, Antonella Tacconelli, et al.
Oncotarget|September 29, 2015
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activityAntonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 16, 2020
Hypoxia-induced alternative splicing: the 11th Hallmark of CancerAntonietta Rosella Farina, Lucia Cappabianca, Michela Sebastiano, et al.
Experimental Cell Research|December 4, 2003
Thioredoxin inhibits microvascular endothelial capillary tubule formationAntonietta R Farina, Antonella Tacconelli, Lucia Cappabianca, et al.
Oncotarget|November 9, 2016
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastomaLuciana Gneo, Pierdomenico Ruggeri, Lucia Cappabianca, et al.
Pageof 3